张月华,博士,2022年博士毕业于四川大学生物治疗国家重点实验室(获药理学博士学位)。2023年进入四川大学华西第二医院放射医学实验室开展博士后研究工作,主要从事辐射损伤机制研究、辐射防护药物的筛选及其成药性评价。以第一作者发表英文文章2篇:《Organic Chemistry Frontiers》和《European Journal of Medicinal Chemistry》。主持承担国家自然科学基金青年基金1项。
【文章发表情况】(#第一作者,*通讯作者)
Yuehua Zhang#, Chunting Wang#, Wei Huang, Phensinee Haruehanroengra, Cheng Peng, Jia Sheng, Bo Han* and Gu He*. Application of organocatalysis in bioorganometallic chemistry: asymmetric synthesis of multifunctionalized spirocyclic pyrazolone-ferrocene hybrids as novel RalA inhibitors. Organic Chemistry Frontiers, 2018, 5(14): 2229-2233.
Yuehua Zhang#, Zhaoping Pan#, Can Chen#, Yiwei Tan, Xiaoyun Wang, Lian Wang, Lu Zhang, Yi Chen*, Gu He*. Design, synthesis and anti-ovarian cancer activities of thieno[2,3-d]pyrimidine based chimeric BRD4 inhibitor/nitric oxide-donator. European Journal of Medicinal Chemistry, 2022, 246: 114970.